DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Ecgonine is an investigational drug.
There have been 5 clinical trials for Ecgonine. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2013.
The most common disease conditions in clinical trials are Cocaine-Related Disorders, Renal Insufficiency, and Opioid-Related Disorders. The leading clinical trial sponsors are National Institute on Drug Abuse (NIDA), Baylor College of Medicine, and Pharmaceutical Project Solutions, Inc.
There are three hundred and eighteen US patents protecting this investigational drug and one international patent.
Recent Clinical Trials for Ecgonine
|Pharmacokinetic Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Subjects With Normal Renal Function||Cognitive Research Corporation||Phase 1|
|Pharmacokinetic Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Subjects With Normal Renal Function||Pharmaceutical Project Solutions, Inc.||Phase 1|
|A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse||Indivior Inc.||Phase 2|
Top disease conditions for Ecgonine
Top clinical trial sponsors for Ecgonine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Ecgonine||See Pricing||Pharmaceutical compositions and methods of using the same||GENUS LIFESCIENCES INC. (Allentown, PA)||See Pricing|
|Ecgonine||See Pricing||Pharmaceutical compositions resistant to abuse||EGALET LTD. (London, GB)||See Pricing|
|Ecgonine||See Pricing||Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation||Allergan, Inc. (Irvine, CA)||See Pricing|
|Ecgonine||See Pricing||Cross-linked hyaluronic acid grafted with dextran||GALDERMA S.A. (Cham, CH)||See Pricing|
|Ecgonine||See Pricing||Pharmaceutical compositions and methods of using the same||GNEUS LIFESCINECES INC. (Allentown, PA)||See Pricing|
|Ecgonine||See Pricing||Hyaluronic acid formulation containing pyruvate||Allergan Industrie, S.A.S. (Pringy, FR)||See Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Ecgonine||European Patent Office||2393487||2029-02-06||See Pricing|
|Ecgonine||European Patent Office||3184105||2029-02-06||See Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|